Canature Health Technology Co., Ltd. (SHE:300272)

SHE:300272 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	1,854	1,841	1,724	1,672	1,661	1,511
Revenue Growth	2.86%	6.77%	3.14%	0.67%	9.87%	27.97%
Gross Profit Gross Profit Growth	724.03	711.46	660.01	615.87	548.75	501.96
Operating Income Operating Income Growth	204.02	200.17	146.77	158.82	129.04	140.39
Net Income Net Income Growth	29.51	56.01	70.39	132.45	92.56	104.86
Earnings Per Share EPS Growth	0.05	0.10	0.12	0.23	0.16	0.18
EPS Growth	-65.38%	-21.48%	-46.84%	41.41%	-9.17%	260.00%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
East China East China Growth	386.2	387.46	363.14	324.38	291.31
North China North China Growth	93.54	85.57	104.6	92.54	121.21
Central China Central China Growth	51.53	55.34	61	53.25	40.34
South China South China Growth	75.19	77.09	109.25	96.81	95.96
Huaxi Huaxi Growth	30.97	28.06	-	-	-
Middle East Middle East Growth	7.52	5.89	3.63	4.45	3.92
Europe Europe Growth	297.23	283.79	244.52	261.71	265.9
Asia Asia Growth	101.54	86.55	75.95	78.22	71.38
North America North America Growth	771.34	690.81	660.06	698.4	571.19
Other Other Growth	25.9	23.7	24.92	29.44	26.25
Total Total Growth	1,841	1,724	1,672	1,661	1,511

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	992.05	1,113	798.14	894.88	413.1	282.02
Total Debt Total Debt Growth	1,407	1,341	1,125	950.5	564.09	314.32
Net Cash (Debt) Net Cash Growth	-414.46	-227.32	-326.76	-55.62	-150.99	-32.3
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.69	-0.39	-0.57	-0.10	-0.27	-0.06

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	307.62	299.61	292.05	374.83	155.44	186.77
Capital Expenditures CapEx Growth	-138.15	-144.72	-130.86	-80.24	-94.58	-71.29
Free Cash Flow Free Cash Flow Growth	169.47	154.89	161.19	294.59	60.85	115.48
Free Cash Flow Growth	5.87%	-3.91%	-45.28%	384.12%	-47.30%	18.70%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	39.05%	38.65%	38.28%	36.84%	33.04%	33.21%
Operating Margin	11.00%	10.87%	8.51%	9.50%	7.77%	9.29%
Pretax Margin	5.28%	5.99%	7.06%	9.50%	6.88%	9.63%
Profit Margin	1.59%	3.04%	4.08%	7.92%	5.57%	6.94%
FCF Margin	9.14%	8.41%	9.35%	17.62%	3.66%	7.64%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Dividend Per Share Dividend Per Share Growth	0.180	0.180	0.160	0.100	0.100	0.100
Dividend Per Share Growth	-47.37%	12.50%	60.00%	0%	0%	100.00%
Dividend Yield	3.02%	2.43%	2.69%	1.75%	2.12%	1.57%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	121.69	81.66	49.37	26.29	31.86	38.89
Forward PE	-	35.24	35.24	35.24	35.24	35.24
P/FCF Ratio	21.47	29.53	21.56	11.82	48.47	35.31
PS Ratio	1.96	2.48	2.02	2.08	1.78	2.70

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error